Ralph Baric | What Does Patent US-7279327-B2 Exist (Methods for Producing Recombinant Coronavirus)? Why Was Remdesivir Used As the Recommended COVID-19 Treatment?
COVID-19 | “In 2002, the University of North Carolina, Chapel Hill Patented An Infectious Replication Defective Clone of Coronavirus. Infectious Replication Defective Means a Weapon.” - Dr. Martin (Read Patents In Description)
The Great Reset | David Martin “In 2002, the University of North Carolina, Chapel Hill Patent An Infectious Replication Defective Clone of Coronavirus. Infectious Replication Defective Means a Weapon.” - Read Patents US7279327B2 & US7220852B1
The Great Reset | "(2002) UNC Filed a Patent On An Infectious Replication Defective Clone of Coronavirus, That Is Supposed to Target Human Cells In a Way That Can Put a Switch Inside of That Thing to Harm the Human Heart & Lung." Dr. Martin
The Great Reset | "UNC Filed a Patent On An Infectious Replication Defective Clone of Coronavirus, That Is Supposed to Target Human Cells In a Way That Can Put a Switch Inside of That Thing to Harm the Human Heart & Lung." - Dr. Martin
Evidence for a connection between coronavirus disease-19 and exposure to radiofrequency radiation from wireless communications including 5G Beverly Rubik and Robert R. Brown